Previous investigations of ovarian and nasopharyngeal cancer have indicated that the inhibition of the NF-κB pathway attenuated pro-tumorigenic effects in fibroblasts and reversed the transformation of NFs into CAFs [75,76]. This evidence concerns the gene NFKB1 and nasopharyngeal carcinoma.